Streetbeat News

Price Targets

SITE

Barclays analyst Matthew Bouley has maintained an Underweight rating on SiteOne Landscape Supply (NYSE:SITE) but increased the price target from $114 to $121.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:48 am

PHM

Barclays analyst Matthew Bouley has maintained an Overweight rating on PulteGroup (NYSE:PHM) and increased the price target from $95 to $120, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:47 am

HLMN

Barclays analyst Matthew Bouley has downgraded Hillman Solutions (NASDAQ:HLMN) from Overweight to Equal-Weight and set a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:47 am

OC

Barclays analyst Matthew Bouley has maintained an Overweight rating on Owens-Corning (NYSE:OC) and increased the price target from $153 to $176.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:46 am

MAS

Barclays analyst Matthew Bouley has maintained an Overweight rating on Masco Corporation (NYSE:MAS) and increased the price target from $63 to $75, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:43 am

LEN

Barclays analyst Matthew Bouley has maintained an Overweight rating on Lennar Corporation (NYSE:LEN) and increased the price target from $132 to $165.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:42 am

VC

Exane BNP Paribas analyst James Picariello has downgraded Visteon (NASDAQ:VC) from Outperform to Neutral and set a price target of $130.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:36 am

ARIS

Seaport Global analyst Jeff Campbell has initiated coverage on Aris Water Solutions, listed as ARIS on the NYSE, with a Buy rating. Additionally, a price target of $15 has been set for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:31 am

ORIC

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on ORIC Pharmaceuticals (NASDAQ:ORIC) but reduced the price target from $16 to $15.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:29 am

RXST

Wells Fargo analyst Larry Biegelsen has upgraded RxSight (NASDAQ:RXST) from Equal-Weight to Overweight and set a price target of $42.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 11:25 am